ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Top Neurology Prescribers in West Virginia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MUHAMMED NASHER-ALNEAM MD

Neurology

11,070

$894K

664
157 are 65+

42%
patients receiving schedule two controlled substances

Avg: 3%

48%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

15%
prescriptions for brand name drugs

Avg: 22%

$81
Average prescription price

Avg: $229

BARRY VAUGHT M.D.

Neurology

7,101

$1.47M

740
433 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

29%
prescriptions for brand name drugs

Avg: 22%

$207
Average prescription price

Avg: $229

WILLIAM MERVA MD

Neurology

6,640

$1.24M

506
291 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 4%

20%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 22%

$187
Average prescription price

Avg: $229

ADNAN ALGHADBAN M.D.

Neurology

6,347

$739K

742
408 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 4%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

15%
prescriptions for brand name drugs

Avg: 22%

$116
Average prescription price

Avg: $229

ALVARO GUTIERREZ M.D.

Neurology

5,706

$716K

388
221 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 22%

$126
Average prescription price

Avg: $229

DARSHANKUMAR DAVE MD

Neurology

5,358

$907K

654
342 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

16%
prescriptions for brand name drugs

Avg: 22%

$169
Average prescription price

Avg: $229

KHALID RAZZAQ MD

Neurology

4,291

$749K

297
202 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

30%
prescriptions for brand name drugs

Avg: 22%

$175
Average prescription price

Avg: $229

SHALU SINGH M.D.

Neurology

4,137

$487K

445
320 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 4%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 22%

$118
Average prescription price

Avg: $229

CARL MCCOMAS MD

Neurology

3,683

$313K

303
195 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

16%
prescriptions for brand name drugs

Avg: 22%

$85
Average prescription price

Avg: $229

FELIX BRIZUELA DO

Neurology

3,625

$6.87M

223
105 are 65+

34%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

48%
prescriptions for brand name drugs

Avg: 22%

$1896
Average prescription price

Avg: $229

ROBERT LEWIS MD

Neurology

3,608

$578K

386
173 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 22%

$160
Average prescription price

Avg: $229

KAROLY VARGA MD

Neurology

3,364

$726K

324
138 are 65+

17%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 22%

$216
Average prescription price

Avg: $229

SAMRINA HANIF MD

Neurology

3,350

$337K

391
176 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 22%

$101
Average prescription price

Avg: $229

KURUVILLA JOHN M.D.

Neurology

3,336

$1.65M

390
193 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

3%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

26%
prescriptions for brand name drugs

Avg: 22%

$495
Average prescription price

Avg: $229

STEPHEN TIMMS MD

Neurology

3,279

$569K

347
245 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

11%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 22%

$173
Average prescription price

Avg: $229

IJAZ AHMAD MD

Neurology

3,195

$821K

246
113 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

11%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

18%
prescriptions for brand name drugs

Avg: 22%

$257
Average prescription price

Avg: $229

MALCOLM LOUDEN MD

Neurology

3,098

$758K

434
241 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 4%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

26%
prescriptions for brand name drugs

Avg: 22%

$245
Average prescription price

Avg: $229

KRIS MURTHY M.D.

Neurology

3,021

$439K

239
95 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 22%

$145
Average prescription price

Avg: $229

JOBY JOSEPH M.D.

Neurology

2,851

$432K

339
190 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 22%

$151
Average prescription price

Avg: $229

SARJIT SINGH M.D.

Neurology

2,794

$581K

354
262 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 4%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 22%

$208
Average prescription price

Avg: $229

RONALD BAREBO MD

Neurology

2,711

$401K

248
169 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

17%
prescriptions for brand name drugs

Avg: 22%

$148
Average prescription price

Avg: $229

DONALD HOFFMAN M.D.

Neurology

2,528

$574K

172
93 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

15%
prescriptions for brand name drugs

Avg: 22%

$227
Average prescription price

Avg: $229

JOE OTHMAN MD

Neurology

2,458

$331K

287
131 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 4%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

37%
prescriptions for brand name drugs

Avg: 22%

$135
Average prescription price

Avg: $229

LEONARD SOLE MD

Neurology

2,447

$568K

281
146 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 22%

$232
Average prescription price

Avg: $229

RITA GANDHY MD

Neurology

2,272

$694K

235
148 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

31%
prescriptions for brand name drugs

Avg: 22%

$305
Average prescription price

Avg: $229

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank